Small Molecule Inhibitors of MDM2-p53 and MDMX-p53 Interactions as New Cancer Therapeutics

Yujun Zhao; Denzil Bernard; Shaomeng Wang

doi:10.7750/BioDiscovery.2013.8.4

Kerstin Brinkmann, Michael Schell, Thorsten Hoppe, Hamid Kashkar (2015)
Regulation of the DNA damage response by ubiquitin conjugation. Frontiers in Genetics 6: .

DOI: 10.3389/fgene.2015.00098

Prosper Obed Chukwuemeka, Haruna Isiyaku Umar, Opeyemi Iwaloye, Oluwaseyi Matthew Oretade, Christopher Busayo Olowosoke, Michael Omoniyi Elabiyi, Festus Omotere Igbe, Oyeyemi Janet Oretade, Joy Oseme Eigbe, Funmilayo Janet Adeojo (2022)
Targeting p53-MDM2 interactions to identify small molecule inhibitors for cancer therapy: beyond “Failure to rescue”. Journal of Biomolecular Structure and Dynamics 40: 9158.

DOI: 10.1080/07391102.2021.1924267

John S. Lazo, Elizabeth R. Sharlow (2016)
Drugging Undruggable Molecular Cancer Targets. Annual Review of Pharmacology and Toxicology 56: 23.

DOI: 10.1146/annurev-pharmtox-010715-103440

S. V. Kurbatov, V. V. Zarubaev, L. A. Karpinskaya, A. A. Shvets, M. E. Kletsky, O. N. Burov, P. G. Morozov, O. I. Kiselev, V. I. Minkin (2014)
Synthesis and antiviral activity of bis-spirocyclic derivatives of rhodanine. Russian Chemical Bulletin 63: 1130.

DOI: 10.1007/s11172-014-0560-4

Sara Gomes, Mariana Leão, Liliana Raimundo, Helena Ramos, Joana Soares, Lucília Saraiva (2016)
p53 family interactions and yeast: together in anticancer therapy. Drug Discovery Today 21: 616.

DOI: 10.1016/j.drudis.2016.02.007

Mariana F da Mota, Alane P Cortez, Polyana L Benfica, Bruna dos S Rodrigues, Thalyta F Castro, Larissa M Macedo, Carlos H Castro, Luciano M Lião, Flávio S de Carvalho, Luiz A S Romeiro, Ricardo Menegatti, Hugo Verli, Bianca Villavicencio, Marize C Valadares (2016)
Induction of apoptosis in Ehrlich ascites tumour cells via p53 activation by a novel small-molecule MDM2 inhibitor – LQFM030. Journal of Pharmacy and Pharmacology 68: 1143.

DOI: 10.1111/jphp.12573

Joana Soares, Nuno A.L. Pereira, Ângelo Monteiro, Mariana Leão, Cláudia Bessa, Daniel J.V.A. dos Santos, Liliana Raimundo, Glória Queiroz, Alessandra Bisio, Alberto Inga, Clara Pereira, Maria M.M. Santos, Lucília Saraiva (2015)
Oxazoloisoindolinones with in vitro antitumor activity selectively activate a p53-pathway through potential inhibition of the p53–MDM2 interaction. European Journal of Pharmaceutical Sciences 66: 138.

DOI: 10.1016/j.ejps.2014.10.006

Alexei N. Izmest′ev, Dmitry B. Vinogradov, Angelina N. Kravchenko, Natalya G. Kolotyrkina, Galina A. Gazieva (2023)
Diastereoselective Synthesis of Dispiro[Imidazothiazolotriazine-Pyrrolidin-Oxindoles] and Their Isomerization Pathways in Basic Medium. International Journal of Molecular Sciences 24: 16359.

DOI: 10.3390/ijms242216359

Siyuan Wang, Yuko Otani, Luhan Zhai, Aoze Su, Masayuki Nara, Masatoshi Kawahata, Kentaro Yamaguchi, Akane Sada, Rieko Ohki, Tomohiko Ohwada (2019)
Overall Shape Constraint of Alternating α/β-Hybrid Peptides Containing Bicyclic β-Proline. Organic Letters 21: 7813.

DOI: 10.1021/acs.orglett.9b02799

Natalia Estrada‐Ortiz, Constantinos G. Neochoritis, Alexander Dömling (2016)
How To Design a Successful p53–MDM2/X Interaction Inhibitor: A Thorough Overview Based on Crystal Structures. ChemMedChem 11: 757.

DOI: 10.1002/cmdc.201500487

Andreas Gollner, Dorothea Rudolph, Heribert Arnhof, Markus Bauer, Sophia M. Blake, Guido Boehmelt, Xiao-Ling Cockroft, Georg Dahmann, Peter Ettmayer, Thomas Gerstberger, Jale Karolyi-Oezguer, Dirk Kessler, Christiane Kofink, Juergen Ramharter, Jörg Rinnenthal, Alexander Savchenko, Renate Schnitzer, Harald Weinstabl, Ulrike Weyer-Czernilofsky, Tobias Wunberg, Darryl B. McConnell (2016)
Discovery of Novel Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one Compounds as Chemically Stable and Orally Active Inhibitors of the MDM2–p53 Interaction. Journal of Medicinal Chemistry 59: 10147.

DOI: 10.1021/acs.jmedchem.6b00900

Santhi Abbaraju, Naresh Ramireddy, Nirmal K. Rana, Hadi Arman, John C.‐G. Zhao (2015)
Organocatalytic Enantioselective Synthesis of Polysubstituted Spirooxindoles using a Tandem Michael–Michael Reaction. Advanced Synthesis & Catalysis 357: 2633.

DOI: 10.1002/adsc.201500298

Valeria Azzarito, Philip Rowell, Anna Barnard, Thomas A. Edwards, Andrew Macdonald, Stuart L. Warriner, Andrew J. Wilson (2016)
Probing Protein Surfaces: QSAR Analysis with Helix Mimetics. ChemBioChem 17: 768.

DOI: 10.1002/cbic.201500504

Anna Barnard, Kérya Long, David J. Yeo, Jennifer A. Miles, Valeria Azzarito, George M. Burslem, Panchami Prabhakaran, Thomas A. Edwards, Andrew J. Wilson (2014)
Orthogonal functionalisation of α-helix mimetics. Org. Biomol. Chem. 12: 6794.

DOI: 10.1039/C4OB00915K

Hiroki Miura, Sachie Terajima, Kentaro Tsutsui, Tetsuya Shishido (2017)
Ruthenium-Catalyzed Addition of Aromatic Amides to Internal Alkynes and Subsequent Intramolecular Cyclization for the Atom-Economical Synthesis of Isoindolinones. The Journal of Organic Chemistry 82: 1231.

DOI: 10.1021/acs.joc.6b02552

Clarisse G. Ricci, J. Andrew McCammon (2018)
Heterogeneous Solvation in Distinctive Protein–Protein Interfaces Revealed by Molecular Dynamics Simulations. The Journal of Physical Chemistry B 122: 11695.

DOI: 10.1021/acs.jpcb.8b07773

A. V. Tkachuk, S. V. Kurbatov, O. N. Burov, M. E. Kletskii, P. G. Morozov, V. I. Minkin (2014)
Synthesis of Spirocyclic Pyrrolizidineoxyindoles with a Furotropylidene Fragment by 1,3-Dipolar Cycloaddition. Chemistry of Heterocyclic Compounds 50: 26.

DOI: 10.1007/s10593-014-1444-0

Clarisse Gravina Ricci, Bo Li, Li-Tien Cheng, Joachim Dzubiella, J. Andrew McCammon (2018)
Tailoring the Variational Implicit Solvent Method for New Challenges: Biomolecular Recognition and Assembly. Frontiers in Molecular Biosciences 5: .

DOI: 10.3389/fmolb.2018.00013

Matthias R. Bauer, Frank M. Boeckler (2013)
Hitting a Moving Target: Targeting Transient Protein States. Structure 21: 2095.

DOI: 10.1016/j.str.2013.11.003

Abdul-Quddus Kehinde Oyedele, Temitope Isaac Adelusi, Abdeen Tunde Ogunlana, Mojeed Ashiru Ayoola, Rofiat Oluwabusola Adeyemi, Musa Oladayo Babalola, James Babatunde Ayorinde, Josiah Ayoola Isong, Toheeb Olakunle Ajasa, Ibrahim Damilare Boyenle (2023)
Promising disruptors of p53-MDM2 dimerization from some medicinal plant phytochemicals: a molecular modeling study. Journal of Biomolecular Structure and Dynamics 41: 5817.

DOI: 10.1080/07391102.2022.2097313

Natalya I. Vasilevich, Ilya I. Afanasyev, Dmitry A. Kovalskiy, Dmitry V. Genis, Valery S. Kochubey (2014)
A Re‐examination of the MDM2/p53 Interaction Leads to Revised Design Criteria for Novel Inhibitors. Chemical Biology & Drug Design 84: 585.

DOI: 10.1111/cbdd.12351

Liam Hayman, Wajeeh Raza Chaudhry, Victor V. Revin, Nikolai Zhelev, Jean-Christophe Bourdon (2019)
What is the potential of p53 isoforms as a predictive biomarker in the treatment of cancer?. Expert Review of Molecular Diagnostics 19: 149.

DOI: 10.1080/14737159.2019.1563484

Constantinos G. Neochoritis, Kan Wang, Natalia Estrada-Ortiz, Eberhardt Herdtweck, Katarzyna Kubica, Aleksandra Twarda, Krzysztof M. Zak, Tad A. Holak, Alexander Dömling (2015)
2,3′-Bis(1′H-indole) heterocycles: New p53/MDM2/MDMX antagonists. Bioorganic & Medicinal Chemistry Letters 25: 5661.

DOI: 10.1016/j.bmcl.2015.11.019

Arup K. Kabi, Raghuram Gujjarappa, Virender Singh, Chandi C. Malakar (2024)
Biological impacts of imidazoline derivatives. Chemical Papers 78: 5743.

DOI: 10.1007/s11696-024-03496-1

Vladimir N. Uversky, Vrushank Davé, Lilia M. Iakoucheva, Prerna Malaney, Steven J. Metallo, Ravi Ramesh Pathak, Andreas C. Joerger (2014)
Pathological Unfoldomics of Uncontrolled Chaos: Intrinsically Disordered Proteins and Human Diseases. Chemical Reviews 114: 6844.

DOI: 10.1021/cr400713r

Shinichi Uesato, Yoshihiro Matsuura, Saki Matsue, Takaaki Sumiyoshi, Yoshiyuki Hirata, Suzuho Takemoto, Yasuyuki Kawaratani, Yusuke Yamai, Kyoji Ishida, Tsutomu Sasaki, Masato Enari (2016)
Discovery of new low-molecular-weight p53–Mdmx disruptors and their anti-cancer activities. Bioorganic & Medicinal Chemistry 24: 1919.

DOI: 10.1016/j.bmc.2016.03.021

Niamh Coleman, Jordi Rodon (2021)
Taking Aim at the Undruggable. American Society of Clinical Oncology Educational Book : e145.

DOI: 10.1200/EDBK_325885

Veronica Kon Graversen, Sai H Chavala (2014)
MDM2 inhibitors in the search for an optimized neovascular age-related macular degeneration treatment. Expert Review of Ophthalmology 9: 355.

DOI: 10.1586/17469899.2014.952225

Rui P.S. Patrício, Paula A. Videira, Florbela Pereira (2022)
A computer-aided drug design approach to discover tumour suppressor p53 protein activators for colorectal cancer therapy. Bioorganic & Medicinal Chemistry 53: 116530.

DOI: 10.1016/j.bmc.2021.116530

Xiaoguang Hao, Ravinder K Bahia, Orsolya Cseh, Danielle A Bozek, Sophia Blake, Jörg Rinnenthal, Ulrike Weyer-Czernilofsky, Dorothea Rudolph, H Artee Luchman (2023)
BI-907828, a novel potent MDM2 inhibitor, inhibits glioblastoma brain tumor stem cells in vitro and prolongs survival in orthotopic xenograft mouse models. Neuro-Oncology 25: 913.

DOI: 10.1093/neuonc/noac271

Aoze Su, Siyuan Wang, Akane Sada, Yuko Otani, Luhan Zhai, Xin Liu, Misa Sayama, Rieko Ohki, Tomohiko Ohwada (2019)
Non-naturally Occurring Helical Molecules Can Interfere with p53–MDM2 and p53–MDMX Protein–Protein Interactions. Chemical and Pharmaceutical Bulletin 67: 1139.

DOI: 10.1248/cpb.c19-00501

Miles Congreve, Fiona H. Marshall (2017)
Pharmacology for Chemists: Drug Discovery in Context. : 45.

DOI: 10.1039/BK9781782621423-00045

Vladimir N. Uversky (2020)
Structural Biology in Drug Discovery. : 587.

DOI: 10.1002/9781118681121.ch25